The embassy at Beijing, China state that Guiyang city expressing interest to procure medicines from Indian companies.
During the visit to Guiyang the officials from department of commerce and Pharmexcil along with leading exporters from India pharma companies are expected to discuss various issues with the Chinese government particularly with regard to fast track registration and speedy clearance for supply of medicines from India.
Pharmaceuticals Export Promotion Council of India (Pharmexcil) has proposed a visit of Indian companies to Guiyang City from 18th-19th October to discuss on the modalities and issues concerning India's export of medicines to the Chinese markets. To take this further, the Council along with department of commerce, government of India and Indian embassy in China are actively pursuing with the Chinese government to organise a meeting at Guiyang city
In view of this, the Pharmexcil is inviting pharma companies in the country to utilise this export opportunity to supply medicines to the Chinese markets and build a greater rapport with the Chinese firms and agencies to sustain a long term export business in the future.
Uday Bhaskar, director general of Pharmexcil said, “We have received a communication from Indian embassy at Beijing.. This is really a great opportunity for the Indian companies to venture into the Chinese markets.”
